UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Features type of response on the diseases in patients with cerebrovascular pathology

Type of Article

In the Section

Index UDK:

Abstract

The type of reaction and the behavior patients is an important part of the successful treatment and recovery, and, respectively, the prolong duration and improve quality of life.

At Kharkiv Regional Clinical Hospital — Emergency and Emergen cy Medicine Center during 2016—2018, observed 383 patients with cerebrovascular pathology (CVP) on different stage of diseases and 47 healthy persons. In research we used questionnaires “Type of response on the disease” and Boston Stress Test.

In the continuum, “healthy — risk group — clinical manifestations of cerebrovascular pathology — after stoke” there is an increase nonadaptive types of response on the disease, manifested by mental stress and the decreasing psychosocial adaptation of patients. Growth of stress combined with types of response on the disease, accompanied by manifestations psychological and psychosocial disadaptation as an intrapsychic, and interphysical mechanism of development.

Psychological correction the type of response on the disease, in particular chronic, with a vital threat and a signifi cant decreasing quality of life as a result of complications and progression, is an important component of psychological help for patients with cerebrovascular pathology based on a health-centered approach.

Pages

References

  1. Mishchenko T. S. Epidemiology of cerebrovascular diseases and organization of care for patients with cerebral stroke in Ukraine // Ukrainian Vysnik Psychoneurology. 2017. Т. 25, vip. 1 (90). С. 22-24.
  2. Diseases of the circulatory system in Ukraine as one of the characteristics of public health / Babak O.Y., Drozdova V.I., Babets A.A. [et al. 2017. № 1. С. 4-11.
  3. Global and regional burden of stroke during 1990—2010: findings from the Global Burden of Disease Study 2010 / V. L. Feigin, М. Н. Forouzanfar, R. Krishnamurthi [et al.] // Lancet. 2014. Vol. 383, No. 9913. P. 245—254. PMID: 24449944.
  4. Prevention of non-communicable diseases / Bilovol OM, Gridnev OE, Isayeva GS [et al. 2016. 352 с.
  5. Stress and diseases of the circulatory system: a manual / edited by V. M. Kovalenko, V. M. Kornatsky. К. : Kolomishyn V. Y., 2015. 352 с.
  6. Ipatov AV, Drozdova IV, Khanyukova IY, Matsuga OM Disability due to diseases of the circulatory system (primary, latent, predicted) // Ukrainian Therapeutic Journal. 2013. № 2. С. 47-53.
  7. Comorbidity and high cardiovascular risk are key issues of modern medicine / Fadeenko GD, Gridnev OE, Nesen AO [et al] // Ukrainian Therapeutic Journal. 2013. № 1. С. 102-107.
  8. Markova MV, Babich VV Medical and psychological aspects of the development and course of diseases of the circulatory system // News of medicine and pharmacy. Neurology and psychiatry. Special issue. 2008. № 243. С. 71-74.
  9. Psychosocial stress and negative influence of macro microsocial factors as a component of the development of circulatory system diseases / Markova MV, Babych VV, Stepanova NM [et al] // Collection of scientific works of the staff of the P.L. Shupyk NMAPE. 2008. № 4. С. 336-348.
  10. Bilovol OM, Panchenko MS, Kicha NV, Kravchenko IM Medical and psychological factors in the prediction of cardiovascular risk // Ukrainian Journal of Extreme Medicine named after G.O. Mozhaev. 2016. Т. 18, № 4. С. 10-16.
  11. White N. , Lenz T. L., Smith K. Tool guide for lifestyle behavior change in a cardiovascular risk reduction program. // Psychol Res  Behav Manag. 2013. Vol.  19, No.  6. Р. 55—63. DOI: https://doi.org/10.2147/PRBM.S40490.
  12. Niewada M., Michel P. Lifestyle modification for stroke prevention: facts and fiction // Curr Opin Neurol. 2016. Vol. 29(1). P. 9—13. DOI: https://doi.org/10.1097/WCO.0000000000000285.
  13. Altenhöner T., Philippi M., Böcken J. Health behavior and changes in health behavior — are education and social status relevant? // Gesundheitswesen. 2014. Vol. 76(1). Р. 19—25. DOI: https://doi.org/10.1055/s-0033-1333729.
  14. Hamood H., Hamood R., Green M. S., Almog R. Determinants of adherence to evidence-based therapy after acute myocardial Infarction // Eur J Prev Cardiol. 2016. Vol. 23(9). P. 975—85. DOI: https://doi.org/10.1177/2047487315597209.
  15. The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis / Du  , Cheng  Z., Zhang Y. [et al.] // Eur J Prev Cardiol. 2017. Vol. 24(9). P. 962—970. DOI: https://doi.org/10.1177/2047487317695628.
  16. Hussain S., Jamal S. , Qadir F. Medication Adherence In Post Myocardial Infarction Patients  // J  Ayub Med  Coll Abbottabad. 2018. Vol.  30(4). P.  552—557. URL: http://www.jamc.ayubmed.edu.pk.552.